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In human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) the gag gene encodes the precursor polyprotein
Pr55Gag, which is cleaved by the viral protease to produce the major structural proteins. Recently, it has been shown that HIV and SIV gag RNAs
contain internal ribosome entry sites (IRESs) that mediate translation of Pr55Gag [Pr57Gag in HIV type 2 (HIV-2)] isoforms. Previously, we
demonstrated that SIVmac239 p43(−), a mutant that does not express the Pr55Gag isoform, SIV p43, replicates more efficiently than wild-type
(WT) SIVmac239 in cell culture. In this study, we characterize SIVmac239 p43(−) virion production and demonstrate that, in the absence of SIV
p43, cleavage of Pr55Gag is increased in budded virions, resulting in a higher percentage of mature particles. Additionally, intracellular cleavage of
Pr55Gag is increased in SIVmac239 p43(−), suggesting that SIV p43 suppresses premature cleavage of Pr55Gag by the viral protease.
© 2006 Elsevier Inc. All rights reserved.Keywords: SIV; Gag; IRES; Maturation; ProteaseIntroduction
In human immunodeficiency virus type 1 (HIV-1) and simian
immunodeficiency virus (SIV) the structural proteins and viral
enzymes are encoded by the gag and pol genes, respectively,
and translated as the precursor polyproteins, Pr55Gag and
Pr160Gag-Pol (Henderson et al., 1990; Jacks et al., 1988; Ratner
et al., 1985). Late in the HIV/SIV lifecycle, Pr55Gag and
Pr160Gag-Pol polyproteins oligomerize in the cytoplasm (Cen et
al., 2004; Chiu et al., 2002; Huang and Martin, 1997; Park and
Morrow, 1992) and are targeted to the plasma membrane of the
host cell (Bryant and Ratner, 1990; Gonzalez et al., 1993;
Henderson et al., 1988; Yuan et al., 1993) where they initiate
budding of the virion. During and after virion budding, the
polyproteins are cleaved by the viral protease (PR) into their
constitutive domains in a process referred to as maturation
(Henderson et al., 1990; Kaplan et al., 1994; Rue et al., 2005;
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doi:10.1016/j.virol.2006.10.003present as a domain within Pr160Gag-Pol, cleaves itself from the
polyprotein (Debouck et al., 1987; Meek et al., 1989).
Subsequently, PR cleaves Pr55Gag into its constituent domains:
matrix (MA), capsid (CA), nucleocapsid (NC), and p6
(Henderson et al., 1990). During maturation, the virion under-
goes a major morphological rearrangement in which CA forms a
cone shaped core around the NC-bound viral RNA, and MA
remains associated with the viral envelope [reviewed in
Gelderblom et al., 1989]. PR also releases the other viral
enzymes, reverse transcriptase (RT) and integrase (IN) from
Pr160Gag-Pol. Maturation of virions is an absolute requirement
for the production of infectious particles (Kaplan et al., 1993;
Kohl et al., 1988; Peng et al., 1989; Pettit et al., 1994).
In addition to expression of Pr55Gag, we and others have
reported the discovery of N-terminally truncated Pr55Gag (Pr57Gag
in HIV-2) isoforms expressed in HIV-1, HIV-2 and SIV (Buck et
al., 2001; Herbreteau et al., 2005;Mervis et al., 1988; Nicholson et
al., 2006). Translation of these isoforms is promoted by internal
ribosome entry sites (IRESs) (Buck et al., 2001; Herbreteau et al.,
2005), which are structural RNA elements that mediate translation
initiation via a cap-independent mechanism [for reviews, see
Hellen and Sarnow, 2001; Vagner et al., 2001]. An interesting
Fig. 1. Replication kinetics of SIVmac239 p43(−). Cell-free supernatants of
CEMX174 cells transfected with wild-type (WT) SIVmac239 or SIVmac239
p43(−) were analyzed on the indicated days post-transfection using a
standard reverse transcription (RT) assay. The values plotted represent the RT
activity of SIVmac239 p43(−) normalized to WT SIVmac239 RT activity at
each time-point from three independent experiments. Inset. Lysates prepared
from COS-1 cells that were transfected with either WT SIVmac239 or
SIVmac239 p43(−) were labeled with [35S]Met/Cys and immunoprecipitated
as described in Materials and methods. Note the absence of SIV p43 in
SIVmac239 p43(−). Figure reprinted from Nicholson et al. (2006) with
permission from Elsevier.
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Pr55Gag isoforms is that they reside entirely within the coding
region of their respective gagmRNAs. Typically, IRESs are found
in the 5′ untranslated region (UTR) of mRNAs.
An additional and intriguing feature of the HIV gag IRESs
(as they will be referred to herein) in particular is that, in
addition to driving expression of the N-terminally truncated
Pr55Gag isoforms, they promote translation of full-length
Pr55Gag from the upstream gag start codon (Buck et al., 2001;
Herbreteau et al., 2005). In contrast, our data suggested that the
SIV gag IRES was not able to efficiently drive expression of
Pr55Gag from the upstream start codon: in vitro translation of a
leaderless gag construct demonstrated that expression of
Pr55Gag was dependent on the 5′ m7G cap structure and was
inhibited in the presence of excess free 5′m7G (Nicholson et al.,
2006). Within the same construct, SIV p43 was translated
efficiently in both cases, indicating that the SIV gag IRES only
functioned to drive expression of SIV p43.
Besides the difference in the ability of the HIV gag IRESs and
the SIV gag IRES to drive expression from an upstream codon,
theHIVPr55Gag isoforms appear to function quite differently than
SIV p43. The HIV Pr55Gag isoforms, HIV-1 p40, HIV-2 p50 and
HIV-2 p44, seem to be required for efficient viral replication
(Buck et al., 2001; Herbreteau et al., 2005). In contrast, an
SIVmac239 mutant that does not express SIVp43 replicates more
efficiently in cell culture than wild-type (WT) SIVmac239
(Nicholson et al., 2006). As of yet, no specific function(s) have
been described for any of the HIV/SIV Pr55Gag isoforms.
In this study, we identify one mechanism by which SIV p43
functions in the viral lifecycle. Characterization of SIVmac239
p43(−) demonstrates that, compared to populations of WT
SIVmac239 virions, populations of SIVmac239 p43(−) virions
have a higher percentage of mature virions. We also demonstrate
that, in the absence of SIV p43, intracellular cleavage of Pr55Gag
is increased, suggesting that SIV p43 suppresses premature
cleavage of full-length Pr55Gag by the viral protease.
Results
Replication kinetics of SIVmac239 p43(−)
Previously, we reported that SIVmac239 p43(−) exhibited
increased replication kinetics in CEMX174 cells compared to
WT SIVmac239 [Fig. 1, reprinted from Nicholson et al., 2006
with permission from Elsevier]. Initially, we focused our ana-
lysis on the last 10 days of the growth curve and reported that,
between days 6 and 16 post-transfection, SIVmac239 p43(−)
replication was increased 2-fold compared to WT SIVmac239.
However, re-examination of these data revealed an aspect of the
growth curve that warranted further investigation: at day 2 post-
transfection, SIVmac239 p43(−) replication is reduced approxi-
mately 75% compared to WT SIVmac239 (Fig. 1). To
investigate the decreased replication of SIVmac239 p43(−) at
day 2 in the growth curve, we simplified our experimental
system in order to characterize a single round of SIVmac239 p43
(−) replication. In addition to accounting for the decreased
replication of SIVmac239 p43(−) at the early time point in thegrowth curve, it was hoped that characterization of a single
round of SIVmac239 p43(−) replication might provide insight
into the later stage increase in replication kinetics of SIVmac239
p43(−) in cell culture compared to WT SIVmac239.
Cleavage of Pr55Gag is enhanced in SIVmac239 p43(−)
To examine a single round of virus replication, 293T cells
were transfected with equal amounts of proviral DNA of either
WT SIVmac239 or SIVmac239 p43(−) and metabolically
labeled with [35S]Met/Cys. Virus particles were purified from
cell supernatants, and both cell lysates and virus lysates were
immunoprecipitated with antibody to SIV capsid (CA) and
resolved by SDS-PAGE (Fig. 2A). Although we transfected the
cells with an equal amount of proviral DNA, we consistently
observed less Pr55Gag in both cell and virus lysates derived from
cells transfected with SIVmac239 p43(−). However, despite the
observed lower levels of Pr55Gag in SIVmac239 p43(−), it
appeared that the CA levels were approximately equivalent in
SIVmac239 p43(−) and WT SIVmac239. Since CA is the final
product of Pr55Gag processing (Pettit et al., 1994), the CA/
Pr55Gag ratio is an indicator of the efficiency of Pr55Gag pro-
cessing by the viral protease; therefore, we calculated the ratio of
CA to Pr55Gag in each lane (Fig. 2B). In both cell and virus
lysates derived from cells transfected with SIVmac239 p43(−),
the ratio of CA/Pr55Gag was increased approximately 2-fold
compared to WT SIVmac239, indicating that proteolytic
cleavage of Pr55Gag is increased in SIVmac239 p43(−).
To control for the possibility that this observation was due to
an unexpected change in antibody recognition due to the M→ I
Fig. 2. Cleavage of Pr55Gag is enhanced in SIVmac239 p43(−). (A) Cell or virus
lysates prepared from 293T cells that were transfected with the control vector
pEGFP-N1, WT SIVmac239 (WT) proviral DNA, or SIVmac239 p43(−)
[p43(−)] proviral DNA and labeled with [35S]Met/Cys were immunoprecipi-
tated with IgG-purified SIV CA polyclonal antiserum. Immunoprecipitates
were resolved by SDS-PAGE and visualized by phosphorimager analysis. (B)
CA and Pr55Gag levels were quantitated by band densitometry of gels from at
least three independent immunoprecipitation experiments, and the ratio of CA/
Pr55Gag was determined.
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immunoprecipitated, [35S]-labeled virus lysates of WT SIV-
mac239 and SIVmac239 p43(−) to SDS-PAGE and phosphor-
imager analysis. Non-immunoprecipitated, virus lysates
exhibited the same increase in CA/Pr55Gag ratio in SIVmac239
p43(−) compared toWT SIVmac239 (data not shown), confirm-
ing that cleavage of Pr55Gag is increased in SIVmac239 p43(−)
compared to WT SIVmac239.
Transmission electron microscopy of SIVmac239 p43(−)
virions
To further characterize a single round of SIVmac239 p43
(−) replication, we examined 293T cells transfected with
either WT SIVmac239 or SIVmac239 p43(−) by transmission
electron microscopy (TEM) (Fig. 3). TEM analysis allowed
for the clarification of several features of SIVmac239 p43(−)
observed in Fig. 2. First, TEM analysis could confirm the
decrease in SIVmac239 p43(−) virion production suggested
by the lower levels of Pr55Gag in SIVmac239 p43(−) virus
lysates compared to WT SIVmac239 virus lysates in Fig. 2.
Second, we could examine the effect of the increased Pr55Gag
cleavage observed in SIVmac239 p43(−) on virion morpho-
logy. It was not clear whether the increased CA/Pr55Gag ratio
in SIVmac239 p43(−) virus lysates indicated that Pr55Gag was
being cleaved at a higher rate within budded virions, or if,
due to the enhanced cleavage of Pr55Gag in the cell, virions
were released with a higher CA/Pr55Gag ratio. If SIVmac239
p43(−) virions had a higher CA/Pr55Gag ratio prior to
budding, the presence of excess CA could affect virion orcore morphology. Alternatively, if cleavage of Pr55Gag was
increased in budded virions, it might be reflected by the
presence of more mature particles in a given population of
SIVmac239 p43(−) virions compared to a population of WT
SIVmac239 virions.
293T cells were transfected with equal amounts of proviral
DNA for either WT SIVmac239 or SIVmac239 p43(−), and
24 h post-transfection cells were fixed and submitted for TEM
analysis. In both samples we observed examples of typical
lentivirus virions: budding virions, immature virions and
mature virions (Fig. 3). We did not observe any gross
morphological differences between WT SIVmac239 and
SIVmac239 p43(−) virions, suggesting that the enhanced
cleavage of Pr55Gag in SIVmac239 p43(−) did not result in
production of aberrant virus particles. We also did not observe
any differences in core morphology in SIVmac239 p43(−)
virions compared to WT SIVmac239 virions. However,
consistent with the data from the immunoprecipitation
experiments presented in Fig. 2, there did appear to be
fewer virions in the SIVmac239 p43(−) samples. Additionally,
it appeared that in the SIVmac239 p43(−) samples, there was a
higher percentage of mature particles than in WT SIVmac239
samples (Fig. 3).
To quantitatively confirm that SIVmac239 p43(−) produced
a higher proportion of mature particles compared to WT
SIVmac239, we compared the percentage of mature virions in
both samples as described in the Materials and methods. Briefly,
in a blinded study, 25 electron micrographs of WT SIVmac239
and SIVmac239 p43(−) were examined, and every completely
budded virion was judged as either immature or mature. Any
virion containing an electron dense outer shell was designated
as immature and any virion containing a condensed core
(conical, centric, or acentric) was designated as mature (Gel-
derblom et al., 1987). Consistent with the apparent reduction in
Pr55Gag levels in both cell and virus lysates in our immuno-
precipitation experiments (Fig. 2), we observed approximately
50% fewer budded SIVmac239 p43(−) virus particles than
WT SIVmac239 particles (Fig. 4). We found that SIVmac239
p43(−) contained 85% mature particles, which was signifi-
cantly higher (p<0.001) than the 57% observed in WT
SIVmac239 (Fig. 4). These data clearly demonstrate that the
increased processing of Pr55Gag in SIVmac239 p43(−) observed
in virus lysates (Fig. 2) reflects an increase in virion maturation
in SIVmac239 p43(−) virions compared to WT SIVmac239
virions.
Characterization of a single round of virus replication by
immunoprecipitation experiments and TEM analysis
prompted us to propose a model that could account for the
increased replication kinetics of SIVmac239 p43(−). In early
rounds of replication in the growth curve experiments (up to
day 2 post-transfection), SIVmac239 p43(−) produces fewer
virions than WT SIVmac239, resulting in lower RT activity
observed in the supernatant. However, the SIVmac239 p43(−)
virions that are produced mature faster and thus are able to
spread more quickly than WT SIVmac239 virions. If the
increased rate of spread compensates and eventually over-
comes the decrease in virion production, the result would be
Fig. 3. Transmission electron micrographs of WT SIVmac239 and SIVmac239 p43(−). 293T cells transfected with WT SIVmac239 or SIVmac239 p43(−) were
harvested 24 h post-transfection, ultra thin-sectioned, and analyzed by transmission electron microscopy. Scale bars represent 100 nm.
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transfection.
Pr55Gag processing in SIVmac239 p43(−) virions
To further examine the increase in maturation of SIVmac239
p43(−) virions, we used an assay previously described by our
laboratory to examine processing of Pr55Gag in budded WT
SIVmac239 and SIVmac239 p43(−) virions over time (Rue et al.,
2005). Briefly, 293T cells transfected with WT SIVmac239 orFig. 4. Percentage of mature virus particles observed for WT SIVmac239 and
SIVmac239 p43(−). The p-value was calculated from a two-sample test for the
difference of proportions.SIVmac239 p43(−) were labeled with [35S]Met/Cys and virus-
containing supernatants were aliquoted and incubated at 37 °C
for different periods of time. At each time point an aliquot was
immediately frozen at −80 °C to stop processing of Pr55Gag. At
the end of the time course all aliquots were thawed, and virus
from each aliquot was purified by centrifugation through a
sucrose cushion, lysed, immunoprecipitated with antibody to CA
and resolved by SDS-PAGE (Figs. 5A, B). It is important to note
that there is a crucial difference in experimental design between
this experiment and the immunoprecipitation experiment in Fig.
2. In the immunoprecipitation experiments, cells were labeled
with [35S] for 4 h to generally characterize SIV protein expression
and virion production. However, in this next experiment, we
wanted to track the maturation of a specific population of budded
virions and therefore reduced the labeling time to 1 h.
We examined the CA/Pr55Gag ratio at each time point in the
6-h time course and found that between 0 and 30 min, the
CA/Pr55Gag ratio was essentially the same in WT SIVmac239
and SIVmac239 p43(−). However, by 1 h, the CA/Pr55Gag ratio
was increased slightly in SIVmac239 p43(−) virions, and had
increased to approximately 1.4-fold by 2 h (Fig. 5C). At the end
of the time course, the CA/Pr55Gag ratio remained approxi-
mately 1.4-fold higher in SIVmac239 p43(−) virions com-
pared to WT SIVmac239 virions. These data confirm that the
CA/Pr55Gag ratio increases over time in SIVmac239 p43(−)
virions at a faster rate than in WT SIVmac239 virions, and
further support our model to explain the observed replication
kinetics of SIVmac239 p43(−) in cell culture.
Fig. 6. Overexpression of SIV p43 result in increased particle production from
WT SIVmac239. 293T cells were co-transfected with WT SIVmac239 and
either the control vector pEGFP-N1, an SIV p43 expression vector, or the
Pr55Gag-alone expression vector, M(118)IMA. Virus-containing supernatants
were assayed for p27 content and data represent the mean and standard deviation
from 6 independent experiments.
Fig. 5. Proteolytic cleavage of Pr55Gag in cell-free SIV virions. 293T cells were
transfected with either the control vector pEGFP-N1, (A) WT SIVmac239
proviral DNA, or (B) SIVmac239 p43(−) proviral DNA and labeled with [35S]
Met/Cys. Virus-containing supernatants were aliquoted and incubated at 37 °C
for the indicated times. At the end of the time course, virus was purified through a
sucrose cushion, lysed, immunoprecipitated with IgG-purified SIV CA
polyclonal antiserum, resolved by SDS-PAGE and visualized using a phos-
phorimager. Gels are representative of three independent experiments. (C) CA
and Pr55Gag levels were quantitated by band densitometry of gels from at least
three independent intravirion cleavage experiments, and the ratio of CA/Pr55Gag
was determined for each time point.
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SIVmac239
Because increased intracellular processing suppresses parti-
cle release (17, 20, 31), a prediction of the model we propose is
that increased levels of SIV p43 would further suppress
intracellular processing thereby increasing particle production
by WT SIVmac239. To test this prediction, we co-transfected293T cells with WT SIVmac239 and either an SIV p43 expres-
sion vector (FSMA) or GFP as a negative control and measured
virus release into the supernatant by p27 ELISA. Compared to
WT SIVmac239 co-transfected with GFP, WT SIVmac239 co-
transfected with SIV p43 produced approximately 50% more
particles, confirming the prediction of our model (Fig. 6). We
wanted to determine whether the observed increase in particle
production was due exclusively to SIV p43, or if any “Gag-like”
protein would have a similar effect. Since the gag gene
expresses not only Pr55Gag, but SIV p43 as well, we co-
transfected WT SIVmac239 with M(118)IMA, a previously
described gag-alone expression vector that carries the mutation
of the start codon of SIV p43 to ATC (Nicholson et al., 2006).
Thus, the use of this expression vector allowed us to examine the
effect of excess Pr55Gag on particle production without
increasing levels of SIV p43. Co-transfection ofWTSIVmac239
with M(118)IMA resulted in similar levels of particle production
observed in co-transfections of WT SIVmac239 with GFP,
strongly indicating that the observed increase in particle
production in the presence of increased levels of SIV p43 was
due exclusively to SIV p43 (Fig. 6).
Discussion
Previously we, and others, identified IRESs within HIV-1,
HIV-2 and SIV gag RNAs that mediate expression of N-
terminally truncated Pr55Gag (Pr57Gag in HIV-2) isoforms
(Buck et al., 2001; Herbreteau et al., 2005; Nicholson et al.,
2006). Here, we report the first function attributed to any of the
HIV/SIV Pr55Gag isoforms and present compelling evidence
that demonstrates SIV p43 acts to suppress proteolytic
processing of Pr55Gag by the viral protease.
This study was initiated to investigate the early replication
kinetics of SIVmac239 p43(−) in cell culture, and our analysis
of a single round of replication has lead us to propose the
following model to describe the observed SIVmac239 p43(−)
replication kinetics over time in cell culture. We propose that
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SIVmac239 in the early phase of the growth curve due to the
decreased production of virions by SIVmac239 p43(−). How-
ever, the increased rate of SIVmac239 p43(−) virion maturation
results in a faster spread of the virus through the cell culture,
ultimately offsetting the decrease in virion production over
time.
While the increased replication kinetics of SIVmac239
p43(−) after day 6 of the CEMX174 growth curve experiment
are intriguing, the most important aspect of SIV p43 observed in
this study may be the apparent decrease in virion production
observed in cells transfected with SIVmac239 p43(−) likely due
to the increase in intracellular cleavage of Pr55Gag in the absence
of SIV p43. Previous reports have demonstrated that over-
expression of the HIV-1 viral protease (PR) increases intracel-
lular cleavage of Pr55Gag, and results in a dramatic reduction in
virion budding and infectivity (Karacostas et al., 1993;
Luukkonen et al., 1995; Shehu-Xhilaga et al., 2001). While
the frameshift mechanism that allows for translation of PR limits
the amount of PR synthesized relative to Pr55Gag, further
regulation of PR activity may be required to ensure cleavage of
Pr55Gag does not occur prematurely (Krausslich, 1991). Thus,
we propose that the major function of SIV p43 may be to
suppress intracellular cleavage of Pr55Gag by the viral protease.
SIV p43 is expressed at low levels relative to Pr55Gag and the
effect it has on cleavage of Pr55Gag is subtle. However, a subtle
effect is most likely all that is required of SIV p43; since
cleavage of Pr55Gag is required for the production of infectious
particles, greater suppression of Pr55Gag processing by SIV p43
could be detrimental to the virus.
What we have contemplated throughout our investigation of
SIV p43, is why SIVmac239 p43(−) exhibits such different
replication kinetics than the HIV mutants that did not express
their respective Pr55Gag isoforms. If we presume that the HIV
IRES-driven Pr55Gag isoforms function similarly to SIV p43 to
suppress intracellular cleavage of Pr55Gag, the difference in
replication kinetics may be reconciled simply by comparing the
processing of Pr55Gag in budded HIV-1 and SIV virions. In this
study and an earlier report, we demonstrate that processing of
SIV Pr55Gag can occur over time in budded virions (Rue et al.,
2005). However, in HIV-1 it is not clear whether intravirion
processing of Pr55Gag occurs; one study suggested that
processing of Pr55Gag occurred either before the virion was
released from the cell, or very shortly after budding (Kaplan et
al., 1994). Also, it is generally agreed that populations of HIV-1
virions contain very few, if any immature budded virions
(compared to the approximate 40% we observe in WT
SIVmac239), strongly supporting the claim that the vast
majority of Pr55Gag processing in HIV-1 occurs prior to virion
release. Thus, if the HIV-1 IRES-driven Pr55Gag isoform, HIV-1
p40, inhibits processing of Pr55Gag, we would expect that in the
absence of HIV-1 p40, processing would occur at a faster rate.
Due to an increase in the rate of intracellular Pr55Gag processing,
it is possible that Pr55Gag could be cleaved in the host cell before
virions could properly assemble and begin budding, resulting in
a profound decrease in virus replication as observed in the case
of HIV-1 p40(−).Thus, although the long-term replication kinetics of the HIV
mutants are exactly opposite of what is observed in SIVmac239
p43(−), they are consistent with the proposed model of SIV p43
function. If it is confirmed that the HIV Pr55Gag isoforms
prevent premature intracellular cleavage of Pr55Gag, they may
provide attractive targets for antiretroviral therapeutic agents.
Materials and methods
DNA constructs
The WT SIVmac239 and SIVmac239 p43(−) viral clones
were previously described (Nicholson et al., 2006). Briefly,
SIVmac239 p43(−) was generated by in vitro mutagenesis of
SIVmac239 pBS− and encoded an ATG→ATC mutation
(mutated base underlined) at ATG118 of the MA domain of
gag. Vectors M(118)IMA and FSMA are based on the gag-alone
expression vector, SIV Pr55GagpCI, and have been previously
described (Nicholson et al., 2006). Briefly, M(118)IMA contains
an ATG→ATC mutation at ATG118 of the MA domain of gag
and has been shown to eliminate expression of SIV p43
(Nicholson et al., 2006). FSMA contains a −1 frameshift at base
53 of the MA domain of SIV gag and has been shown to
express SIV p43 but not SIV Pr55Gag.
Cell culture and metabolic labeling
Human embryonic kidney 293T cells (American Type
Culture Collection, Manassas, Virginia) were maintained as
previously described (Rue et al., 2003). 293T cells at ∼40%
confluence were transfected in T-75 flasks with 9.75 μg DNA or
T-150 flasks with 21 μg DNA using Lipofectamine Plus
(Invitrogen) according to the manufacturer's instructions.
Twenty-four hours post-transfection, cells were labeled with
[35S]Met/Cys for 4 h as previously described (Nicholson et al.,
2006). Radiolabeled cells were washed in phosphate-buffered
saline (PBS), lysed in modified radioimmunoprecipitation assay
(RIPA) buffer (PBS with 1% [vol/vol] Igepal [NP-40], 0.5%
[wt/vol] sodium deoxycholate, 0.1% [wt/vol] sodium dodecyl
sulfate [SDS], 1 mM sodium orthovanadate, and protease
inhibitor cocktail III [Calbiochem]), and clarified by sonication
and centrifugation. Cell supernatants were filtered through a
Millex 0.45-μm-pore-size syringe-tip filter (Millipore), and
radiolabeled virus was pelleted through a 20% sucrose cushion
in TNE buffer (20 mM Tris [pH 8.0], 150 mM NaCl, and 2 mM
EDTA) at 133,000×g for 2 h at 4 °C. Virus pellets were then
lysed in RIPA buffer.
For immunoprecipitations, radiolabeled cell (500 μg) and
virus lysates were incubated with 3 μg of immunoglobulin G
(IgG)-purified rabbit SIV CA polyclonal antiserum (HRP) for
1 h at 4 °C, followed by an overnight incubation with protein
A–agarose beads (Sigma-Aldrich) at 4 °C. Protein A–agarose
beads were pelleted and washed with RIPA buffer and proteins
were resolved by SDS-PAGE using 12.5% Tris–HCl Criterion
pre-cast gels (Bio-Rad). Fixed gels were analyzed using a
Typhoon 9210 phosphorimager and Molecular Dynamics
ImageQuant version 5.5 software (Amersham Pharmacia).
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293 T cells were transfected as described above with proviral
DNA for either WT SIVmac239 or SIVmac239 p43(−). One
day post-transfection, the cells were pelleted and fixed at 4 °C in
2.5% glutaraldehyde in Millonig's sodium phosphate buffer for
2 h and washed three times with Millonig's sodium phosphate
buffer. Samples were submitted to Electron Microscopy
Bioservices, LLC (EMBS, Frederick, MD) for ultra-thin
sectioning and analysis.
Virion morphology comparison
The proportion of mature virions in WT SIVmac239 and
SIVmac239 p43(−) samples was determined as follows:
completely budded virions in 25 photomicrographs of each
virus sample were assessed as either immature or mature. In
order to minimize bias in the study, two individuals analyzed
photomicrographs that were randomly ordered and numbered
by an outside individual. The proportion of mature particles for
each viral clone were compared using a two-sided, two sample
test of proportions (Rosner, 2000).
Analysis of proteolytic processing of Pr55Gag in budded virions
Proteolytic processing of Pr55Gag in budded virions was
carried out as previously described (Rue et al., 2005). Briefly,
293T cells were transfected as described above with proviral
DNA for either WT SIVmac239 or SIVmac239 p43(−) and
labeled with [35S]Met/Cys as described above, except for only
1 h. Virus-containing supernatants were filtered, aliquoted, and
incubated at 37 °C for different periods of time. At each time
point, an aliquot was immediately frozen at −80 °C in order to
stop processing. At the end of the time course, all aliquots were
thawed in an ice bath. Virus from each aliquot was purified by
centrifugation through a sucrose cushion, lysed and immuno-
precipitated with antibody to CA as described above.
Co-transfections and SIV p27 ELISA
For co-transfection experiments, 293T cells were transfected
in 6-well plates with 2 μg total DNA (1 μg each plasmid) using
Lipofectamine Plus (Invitrogen) according to the manufac-
turer's instructions. 24 h post-transfection, virus-containing
supernatants were pelleted briefly to remove cell debris and
assayed for p27 production with the SIV core antigen assay kit
(Coulter).
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